Telaprevir-induced acute kidney injury during treatment of chronic hepatitis C.
暂无分享,去创建一个
[1] Z. Lv,et al. Helicobacter pylori infection and normal colorectal mucosa–adenomatous polyp–adenocarcinoma sequence: a meta‐analysis of 27 case–control studies , 2014, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.
[2] T. Rokkas,et al. The relationship of Helicobacter pylori infection and colon neoplasia, on the basis of meta-analysis , 2013, European journal of gastroenterology & hepatology.
[3] J. Kountouras,et al. Impact of Helicobacter pylori Infection on Colon Oncogenesis , 2013, American Journal of Gastroenterology.
[4] M. Ghany,et al. An Update on Treatment of Genotype 1 Chronic Hepatitis C Virus Infection: 2011 Practice Guideline by the American Association for the Study of Liver Diseases , 2011, Hepatology.
[5] G. Everson,et al. Telaprevir with peginterferon and ribavirin for chronic HCV genotype 1 infection. , 2009, The New England journal of medicine.
[6] N. Kapetanakis. Association of Helicobacter pylori Infection with Colorectal Cancer , 2013 .
[7] N. Hayashi,et al. Telaprevir with peginterferon and ribavirin for treatment-naive patients chronically infected with HCV of genotype 1 in Japan. , 2012, Journal of hepatology.